Impact of genotyping on outcome of prostatic biopsies: A multicenter prospective study

Molecular Medicine

Volumn 17, Issue 5-6, 2011, Pages 473-477

  Cornu, Jean Nicolas ^a,b   Drouin, Sarah ^a,b,c   Cancel Tassin, Géraldine ^a,b   Bigot, Pierre ^d   Azzouzi, Abdel Rahmène ^a,d   Koutlidis, Nicolas ^e   Cormier, Luc ^a,e   Gaffory, Cécile ^a,b   Rouprêt, Morgan ^a,b,c   Sèbe, Philippe ^a   Bitker, Marc Olivier ^c   Haab, François ^a   Cussenot, Olivier ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGITAL RECTAL EXAMINATION; ETHNICITY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BIOPSY; GENOTYPE; HUMANS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 79957958118     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00205     Document Type: Article

References (21)

1. Jemal A, Siegel R, Xu J, Ward E. (2010) Cancer statistics, 2010. CA Cancer J. Clin. 60:277-300
2. Marberger M, et al. (2008) New treatments for localized prostate cancer. Urology. 72:S36-S43.
3. Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW. (2008) An updated catalog of prostate cancer predictive tools. Cancer. 113:3075-3099.
4. Nogueira L, Corradi R, Eastham JA. (2010) Other biomarkers for detecting prostate cancer. BJU Int. 105:166-169.
5. Lughezzani G, et al. (2010) Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur. Urol. 58:687-700.
6. Gudmundsson J, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39:631-637.
7. Yeager M, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39:645-649.
8. Pal P, et al. (2009) Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry. Prostate. 69:1548-1556.
9. Suuriniemi M, et al. (2007) Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol. Biomarkers Prev. 16:809-814.
10. Wang L, et al. (2007) Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res. 67:2944-2950.
11. Cussenot O, et al. (2008) Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. Clin. Cancer Res. 14:5635-5639.
12. Hamano T, et al. (2010) Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease. J. Urol. 184:738-742.
13. Wiklund FE, et al. (2009) Established prostate cancer susceptibility variants are not associated with disease outcome. Cancer Epidemiol. Biomark-ers Prev. 18:1659-1662.
14. Penney KL, et al. (2009) Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clin. Cancer Res. 15:3223-3230.
15. Salinas CA, et al. (2009) Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate. 69:363-372.
16. Cheng I, et al. (2010) Prostate cancer susceptibility variants confer increased risk of disease progression. Cancer Epidemiol. Biomarkers Prev. 19:2124-2132.
17. Xu J, et al. (2010) Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 107:2136-2140.
18. Nam RK, et al. (2009) Utility of incorporating genetic variants for the early detection of prostate cancer. Clin. Cancer Res. 15:1787-1793.
19. Amundadottir LT, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38:652-658.
20. Fitzgerald LM, et al. (2009) Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin. Cancer Res. 15:3231-3237.
21. Zheng SL, et al. (2008) Cumulative association of five genetic variants with prostate cancer. N. Engl. J. Med. 358:910-919.